HealthSeq Study Offers Healthy New Yorkers Whole Genome Sequencing
Saskia Sanderson, PhD, Professor of Genetics at the Icahn School of Medicine at Mount Sinai, is a lead author of a paper published this June in the European Journal of Human Genetics, which described findings from HealthSeq, a project aimed at gauging reactions to whole genome sequencing. In the HealthSeq study, 35 individuals with no pressing medical reason to have their DNA tested were offered whole genome sequencing through the Icahn Institute of Genomics and Multiscale Biology, and were interviewed about medical, privacy, and security concerns before and after receiving their data. "We did want to recruit people from a wider range of backgrounds, who were not just the wealthy people who could afford to spend thousands of dollars doing this, or who could do it because they are scientists themselves." The goal was to learn if patients would agree to participate in whole genome sequencing if offered.
-Saskia Sanderson, PhD, Adjunct Assistant Professor, Genetics and Genomic Sciences, Icahn School of Medicine at Mount Sinai
.jpg)
Childhood Asthma Study Uncovers Risky Air Pollutant Mixtures
Oct 06, 2021 View All Press Releases
Mount Sinai Researchers Discover Treatment Option for Rare Genetic Disorder
Aug 04, 2020 View All Press ReleasesMount Sinai Researchers: Why COVID-19 May Be Less Common in Children Than Adults
May 22, 2020 View All Press ReleasesGlobal Team Enables Child With a Fatal Genetic Disease to Recover
Jan 16, 2020 View All Press ReleasesIntegrated, Multi-“omic” Studies of Asthma Could Lead to Precision Treatment
Jul 02, 2019 View All Press Releases